Medipal Holdings CorporationTSE: 7459

Notice Regarding Dividends of Retained Earnings (Dividend Increase)

· Issued by Medipal Holdings Corporation

May 14, 2026

MEDIPAL HOLDINGS CORPORATION

Representative: Shuichi Watanabe, Representative Director, President and CEO

Code number: 7459 (Prime Market, Tokyo Stock Exchange) Contact: Toshiyuki Ikeuchi, Executive Officer,

Head of Corporate Communications Department, Corporate Planning Division

Tel: +81-3-3517-5171

Notice Regarding Dividends of Retained Earnings (Dividend Increase)

At a meeting of the Board of Directors held on May 14, 2026, MEDIPAL HOLDINGS CORPORATION ("MEDIPAL") resolved to pay a dividend of retained earnings with a record date of March 31, 2026. The details are as follows.

  1. Details of year-end dividend

    Determined amount

    Previous forecast (Announced on

    May 13, 2025)

    Actual results for the fiscal year

    (Fiscal year ended March 31, 2025)

    Record date

    March 31, 2026

    March 31, 2026

    March 31, 2025

    Dividend per share

    ¥34.00

    ¥32.00

    ¥32.00

    Total amount of dividends

    ¥6,959 million

    -

    ¥6,654 million

    Effective date

    June 2, 2026

    -

    June 3, 2025

    Source of dividends

    Retained earnings

    -

    Retained earnings

  2. Reason

MEDIPAL considers returns to shareholders one of its highest management priorities. MEDIPAL is pursuing the optimal capital structure while ensuring financial soundness, and, as a general principle, will maintain or increase its dividend payout ratio on earnings before amortization of goodwill and

intangible assets arising from the growth investments set forth in the "2027 MEDIPAL Medium-Term Vision ―Change the Oroshi Forever―Constant Innovation". Simultaneously, MEDIPAL will

comprehensively assess demand for funding and flexibly implement share buybacks and cancellations of shares as appropriate for the purpose of improving capital efficiency and further returning profits to shareholders.

In consideration of the aforementioned policy and the financial condition for the fiscal year as well as other factors, MEDIPAL has decided to revise the year-end dividend for the fiscal year ended March 31, 2026 to ¥34.00 per share, an increase of ¥2.00 from the previous forecast.

As a result, total dividends for the fiscal year is ¥66.00 per share, including the interim dividend (end of 2nd quarter) of ¥32.00 that was already paid.

<Reference>Breakdown of annual dividends

Dividends per Share (Yen)

End of 2nd quarter

Year-End

Total

Fiscal year ended March 31, 2026

32.00

34.00

66.00

Fiscal year ended March 31, 2025

30.00

32.00

62.00

# # #

The English version of this document is a translation of the Japanese original and is provided for information purposes only. While reasonable efforts have been made to provide an accurate translation, no liability is assumed by MEDIPAL HOLDINGS CORPORATION for any errors, omissions, or ambiguities in the translation. In the event of any inconsistency

or conflict between the English version and the Japanese original, the Japanese original shall prevail.

Earlier from Medipal

All Medipal news releases